NCT04031885 2021-08-24
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Phase 4 Terminated
Clinical Trials
5 trialsNCT01588990 2019-01-22
ASCENT
Hoffmann-La Roche
Phase 4 Completed
NCT00502671 2015-09-03
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Hoffmann-La Roche
Phase 4 Completed
NCT00127933 2011-08-10
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00121836 2011-04-27
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Completed